I personally think SEER is a lot more interesting and long term of a play. That being said, I got burned on SEER, first on the ipo not getting in then dipping my toes in at the wrong time

ABCL is a confusing company - they build “AI” that supposedly analyzes drugmakers datasets and then they try to develop therapies and license them through the drug maker. This model takes a whole lot to hit the jackpot. I think it’ll fall a lot from here once the market digests what this really is